Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease
This study has been completed.
Study NCT00901498 Information provided by Bristol-Myers Squibb
First Received on May 5, 2009. Last Updated on January 6, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alzheimer's Disease
Healthy
Additional conditions recognized in this trial
Alzheimer Disease
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies
Interventions listed in this trial
BMS-708163
Sponsors listed in this trial
Bristol-Myers Squibb
Back to top of Main Content